Enjoy complimentary customisation on priority with our Enterprise License!
There is a growing need to combat various emerging rare diseases and discover new therapies for existing conditions and the pharmaceutical industry is witnessing a significant rise in investments towards research. Additionally, there is also an increase in investments made in the R&D for biotechnology companies. The US is the largest investor in biotechnology and has invested a total amount of about USD 30 billion in 2015. France is another major investor and the country has witnessed an investment of almost USD 4 billion. With the growing trend of increased R&D spending, the demand for nanobiotechnology will increase during the forecast period, fueling market growth.
Want a bigger picture? Try a FREE sample of this report now!
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 05: MARKET SIZING
PART 06: FIVE FORCES ANALYSIS
PART 07: MARKET SEGMENTATION BY END-USER
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
PART 14: VENDOR ANALYSIS
PART 15: APPENDIX
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.